MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial
MIMEDX GROUP (NASDAQ: MDXG) Delayed: 4.43 -0.12 (2.64%)
Previous Close $4.55    52 Week High $9.90 
Open $4.54    52 Week Low $6.64 
Day High $4.61    P/E N/A 
Day Low $4.35    EPS $-0.05 
Volume 841,629